Medical Review

The Six Years of Oncotarget

Oncotarget is an open access medical journal in the English Language. It is a multidisciplinary peer-reviewed journal and weekly published by Impact Journals. The magazine was launched in 2010. Andrei V. Gudkov and Mikhail Blagosklonny are the editors-in-chief of Oncotarget. Bibliographic databases like Scopus, Index Medicus, Science Citation Index Expanded, MEDLINE, BIOSIS Previews, and PubMed have indexed and abstracted Oncotarget. Despite having a great repute, it has been criticized for its reviewing process on Among all journals in Oncology, Oncotarget ranks No.01. It has an impact factor of 5.415 according to the Journal Citation Reports.

The mission of Oncology is to make science research widely and rapidly available, and have no borders between specialties. The primary focus of Oncotarget is to publish research papers in cancer. However, the journal also needs to publish papers in other fields due to complex nature of tumor development, and its connection with other things. Therefore, it is contributing to the scientific progress under the leadership of well-known scientists. Due to its success, Oncotarget decided to launch more sections. The current sections of the journal are Pharmacology, Cardiology, Aging, Metabolism, Microbiology, Cell & Mol Biology, Neuroscience, and Endocrinology.

The journal follows COPE Code of Conduct for Journal Editors and Publishers. Editors, reviewers, and authors follow ICJME’s Recommendations for ethical behavior guidelines on Brief guidelines for editors, authors, and reviewers are also available on the journal’s website. It is highly recommended that authors read the publishing policies before they submit an article.

People can access the archives of Oncotarget on its website. All volumes of the journal from 2010 to 2016 are uploaded there. Anyone can download and print articles for his research work. To speed up the search, Oncotarget has provided a special search feature on its website. All one has to do is to write some details like the category, author’s name, title, date, discipline, and keyword(s). Within a few seconds, that article will be on the screen. The editors of Oncotarget are aware of the importance of social media. Therefore, the journal has accounts on popular social media websites like Facebook, Twitter, YouTube, Google+, and LinkedIn.

Oncotarget has the honor of publishing two highly important research studies. On January 2013, the journal published a study titled MET amplification as a potential therapeutic target in gastric cancer. On November 2016, Oncotarget published a study which showed that E-cigarettes damaged gum tissues. Professor Irfan Rahman of UR School of Medicine and Dentistry led the study. Reference:

One Comments

  • Kimberly Miles

    June 6, 2017

    I have always thought that radical research and medical experimentations with cancers are the way out to cancer breakthrough. Although essay-on-time review still have contents that are good medical reviews to support it.

Comments are closed.